{
"NDC": {
"NDCCode": "69315-174-60",
"PackageDescription": "60 mL in 1 BOTTLE (69315-174-60) ",
"NDC11Code": "69315-0174-60",
"ProductNDC": "69315-174",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Oseltamivir Phosphate",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Oseltamivir Phosphate",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20220601",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA214949",
"LabelerName": "Leading Pharma, LLC",
"SubstanceName": "OSELTAMIVIR PHOSPHATE",
"StrengthNumber": "6",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-10-09",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20251231",
"StartMarketingDatePackage": "20220601",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}